NPPA still to recover Rs 8098.78 crore from pharma firms for overcharging Medical Dialogues Team29 Dec 2021 6:41 PM ISTNew Delhi: The total outstanding amount pending to be paid by the pharmaceutical companies for alleged overcharging stands at Rs 8,098.78 crore, the...
AstraZeneca to study cancer drug Datopotamab deruxtecan in India Medical Dialogues Team27 Dec 2021 6:39 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Cipla gets CDSCO panel nod to market antineoplastic drug Hydroxyurea Medical Dialogues Team26 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major Cipla has got a go ahead from from the Subject Expert Committee (SEC) functional under the Central...
Ibuprofen makers to add adverse reaction Stevenson Johnson Syndrome in package insert: CDSCO panel Medical Dialogues Team25 Dec 2021 5:04 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
22 drug samples fail to qualify CDSCO test, Details Medical Dialogues Team23 Dec 2021 5:31 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 22 medicine...
Delhi HC restrains Natco from infringing Novartis API containing Eltrombopag Olamine Medical Dialogues Team22 Dec 2021 6:26 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained Natco Pharma from using, manufacturing , importing, selling, offering...
NIB Noida notified as Central Drugs Laboratory to test COVID vaccines Medical Dialogues Team21 Dec 2021 7:53 PM ISTNew Delhi: In major public interest, with the aim of regulating the testing of the COVID-19 vaccine for prevention and management of COVID-19...
AstraZeneca gets CDSCO panel nod to study lupus erythematosus drug Anifroluma Medical Dialogues Team19 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the...
Sun Pharma Rosuvastatin Sprinkle Capsules get CDSCO panel okay Medical Dialogues Team18 Dec 2021 6:03 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Conduct clinical trial in Indian patient: CDSCO panel tells Glenmark on pulmonary drug study Medical Dialogues Team17 Dec 2021 6:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has directed Glenmark to conduct a Phase 3...
Covishield booster dose cannot be recommended without clinical trials: CDSCO panel Medical Dialogues Team16 Dec 2021 6:16 PM ISTAmid the emergence of the new Covid variant Omicron, the SII had sought approval to administer the booster dose of its Covishield vaccine on the basis...
NPPA panel fixes retail price of Alkem marketed Amoxicillin, Clavulanate FDC Medical Dialogues Team15 Dec 2021 6:36 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of each 5ml of the reconstituted suspension ...
